bullish

Orexo AB

Orexo - Vorvida submitted to the FDA

840 Views10 Mar 2020 14:54
Issuer-paid
SUMMARY

Orexo announced on 6 March 2020 that it has submitted an application to the FDA for its vorvida digital therapy for the treatment of heavy drinking. It expects a hearing from the FDA on the approval status of the program in Q220 and to commercialize the product in H220 if it is cleared. The product uses cognitive behavioral therapy coupled with machine learning and has been vetted in a randomized, controlled study to reduce problematic drinking episodes.

Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Orexo - Vorvida submitted to the FDA
    10 Mar 2020
x